Effect of hepatic glycogen level on hepatic glucose uptake and disposition
肝糖原水平对肝葡萄糖摄取和处置的影响
基本信息
- 批准号:7408366
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBlood GlucoseCanis familiarisConsciousDiabetes MellitusDiseaseElevationFastingFructoseGlucagonGlucoseGlycogenHepaticHormonesHourInfusion proceduresInsulinIslets of LangerhansKnowledgeLeadLiverLiver GlycogenMuscleNon-Insulin-Dependent Diabetes MellitusOralPeripheralPharmaceutical PreparationsPopulationProcessPublic HealthRateSalineSignal TransductionTimefeedingglucose metabolismglucose uptakeimprovedresponseuptake
项目摘要
DESCRIPTION (provided by applicant): In response to an oral glucose load, the liver takes up and stores one-third of ingested glucose, a process that is altered by type 2 diabetes mellitus. Earlier studies from our lab have provided information concerning factors that regulate hepatic glucose uptake, including glucose load to the liver, insulin level, and portal glucose delivery. Elevation of muscle glycogen reduces glucose uptake and glycogen synthesis, however the effect of hepatic glycogen level on hepatic glucose uptake and disposition is not known. To investigate this topic, we will use the 18 hour fasted conscious dog. During the first four hours of each study, all animals will receive peripheral infusion of SRIF to disable the endocrine pancreas, and basal intraportal replacement of insulin and glucagon. Coincidently, glucose load to the liver will be doubled, and an intraportal infusion of saline or fructose will be started. Fructose will be given at rates calculated to increase hepatic glycogen by 40 and 80 mg/g, respectively. The fructose infusion will be followed by a two hour control period, during which basal replacement of hormones and substrates (except fructose) will continue, allowing hepatic glucose metabolism to return to baseline. The final two hours (i.e., the experimental period) will be characterized by either the intraportal infusion of insulin at four times basal, or insulin infusion plus intraportal infusion of glucose at a rate of 4 mg/kg/min. In this way we will be able to examine the effect of hepatic glycogen loading on the ability of insulin to alter net hepatic glucose uptake and hepatic glucose disposition. We will also be able to determine the impact of hepatic glycogen loading on the impact of the portal glucose signal on hepatic uptake of glucose and its fate in the liver.
PUBLIC HEALTH RELEVANCE: In response to feeding, the liver takes up a significant amount of the glucose load, a process that is impaired in people with type 2 diabetes mellitus, contributing to the high blood glucose levels seen in this population. Medications for the treatment of diabetes mellitus are being developed to increase uptake and storage of glucose by the liver, but the effect of increasing liver glycogen levels is not known, and may limit the utility of such approaches. More needs to be known about the impact of hepatic glycogen on glucose metabolism by the liver, as such knowledge could lead to an improved understanding of disease states that are characterized by impaired hepatic glucose uptake, such as type 2 diabetes mellitus.
描述(由申请人提供):响应口服葡萄糖负荷,肝脏吸收并储存三分之一的摄入葡萄糖,这一过程因 2 型糖尿病而改变。我们实验室的早期研究提供了有关调节肝脏葡萄糖摄取的因素的信息,包括肝脏的葡萄糖负荷、胰岛素水平和门静脉葡萄糖输送。肌糖原升高会减少葡萄糖摄取和糖原合成,但肝糖原水平对肝脏葡萄糖摄取和处置的影响尚不清楚。为了研究这个主题,我们将使用 18 小时禁食、神志清醒的狗。在每项研究的前四个小时内,所有动物将接受外周输注 SRIF 以禁用内分泌胰腺,并接受基础门脉内胰岛素和胰高血糖素替代。巧合的是,肝脏的葡萄糖负荷将加倍,并且将开始门静脉内输注盐水或果糖。果糖的施用量经计算可分别增加肝糖原 40 和 80 mg/g。果糖输注后将有一个两小时的控制期,在此期间将继续激素和底物(果糖除外)的基础替代,使肝脏葡萄糖代谢恢复到基线。最后两小时(即实验期)的特点是按基础四倍的门静脉内输注胰岛素,或以 4 mg/kg/min 的速率输注胰岛素加门静脉内输注葡萄糖。通过这种方式,我们将能够检查肝糖原负荷对胰岛素改变肝葡萄糖净摄取和肝葡萄糖处置能力的影响。我们还将能够确定肝糖原负荷对门静脉葡萄糖信号对肝脏对葡萄糖的摄取及其在肝脏中的命运的影响的影响。
公共健康相关性:在进食时,肝脏会吸收大量的葡萄糖负荷,这一过程在 2 型糖尿病患者中会受到损害,从而导致该人群出现高血糖水平。正在开发治疗糖尿病的药物以增加肝脏对葡萄糖的吸收和储存,但增加肝糖原水平的效果尚不清楚,并且可能限制此类方法的实用性。我们需要更多地了解肝糖原对肝脏葡萄糖代谢的影响,因为这些知识可以帮助我们更好地了解以肝葡萄糖摄取受损为特征的疾病状态,例如 2 型糖尿病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason Winnick其他文献
Jason Winnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason Winnick', 18)}}的其他基金
Effect of Liver Glycogen Content on Hypoglycemic Counterregulation
肝糖原含量对低血糖反调节的影响
- 批准号:
9925082 - 财政年份:2016
- 资助金额:
$ 4.68万 - 项目类别:
On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia
胰岛素所致低血糖过程中肝脏糖代谢的调节作用
- 批准号:
10441931 - 财政年份:2016
- 资助金额:
$ 4.68万 - 项目类别:
Effect of liver glycogen content on hypoglycemic counterregulation
肝糖原含量对降血糖反调节的影响
- 批准号:
9389238 - 财政年份:2016
- 资助金额:
$ 4.68万 - 项目类别:
Effect of liver glycogen content on hypoglycemic counterregulation
肝糖原含量对降血糖反调节的影响
- 批准号:
9102665 - 财政年份:2016
- 资助金额:
$ 4.68万 - 项目类别:
Effect of liver glycogen content on hypoglycemic counterregulation
肝糖原含量对降血糖反调节的影响
- 批准号:
9271184 - 财政年份:2016
- 资助金额:
$ 4.68万 - 项目类别:
The effect of exercise on hepatic glucose metabolism in type 2 diabetes mellitus
运动对2型糖尿病肝脏糖代谢的影响
- 批准号:
8713984 - 财政年份:2012
- 资助金额:
$ 4.68万 - 项目类别:
The effect of exercise on hepatic glucose metabolism in type 2 diabetes mellitus
运动对2型糖尿病肝脏糖代谢的影响
- 批准号:
8383367 - 财政年份:2012
- 资助金额:
$ 4.68万 - 项目类别:
The effect of exercise on hepatic glucose metabolism in type 2 diabetes mellitus
运动对2型糖尿病肝脏糖代谢的影响
- 批准号:
8534863 - 财政年份:2012
- 资助金额:
$ 4.68万 - 项目类别:
Effect of hepatic glycogen level on hepatic glucose uptake and disposition
肝糖原水平对肝葡萄糖摄取和处置的影响
- 批准号:
7579834 - 财政年份:2008
- 资助金额:
$ 4.68万 - 项目类别:
相似国自然基金
可穿戴无创血糖监测和可控给药器件的构建及应用
- 批准号:22304037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血糖水平与认知下降的前瞻性关联及动脉硬化的中介效应和DNA甲基化机制研究
- 批准号:82373665
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
α-1,6-半乳聚糖靶向CD81调节血糖的构效关系及作用机制
- 批准号:32371341
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
反复非严重低血糖通过星形胶质细胞SIRT3-脂肪酸代谢重塑诱导认知障碍的机制研究
- 批准号:82301352
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA去甲基化酶通过调控SIK1的RNA甲基化水平参与妊娠高血糖疾病的胎盘合胞化机制研究
- 批准号:82371688
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Vitamin D and Healthy Aging: Establishing the Sled Dog Sentinel for the Circumpolar North
维生素 D 与健康老龄化:为北极圈建立雪橇犬哨兵
- 批准号:
10649356 - 财政年份:2023
- 资助金额:
$ 4.68万 - 项目类别:
New anti-glioblastoma metabolic compounds with high potential for Blood Brain Barrier penetration
新型抗胶质母细胞瘤代谢化合物具有穿透血脑屏障的巨大潜力
- 批准号:
10543931 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
Clinical grade insulin-producing iPSCs encapsulated with durable hyaluronic acid for long-term treatment of type 1 diabetes
临床级产生胰岛素的 iPSC 封装有耐用的透明质酸,用于长期治疗 1 型糖尿病
- 批准号:
10322774 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
一项 0 期试点研究,以确定罂粟碱是否会增加自发性犬软组织肉瘤的氧合
- 批准号:
9985010 - 财政年份:2019
- 资助金额:
$ 4.68万 - 项目类别:
Ninja Theranostics for overcoming the drug delivery barriers to pediatric brain tumor
Ninja Theranostics 克服儿童脑肿瘤的药物输送障碍
- 批准号:
9681305 - 财政年份:2018
- 资助金额:
$ 4.68万 - 项目类别: